glp 1 electrolyte imbalance Why Are Electrolytes Important on a GLP-1 Medication? – Bolt Pharmacy Does GLP-1 Cause Muscle Cramps?

Furthermore, healthcare providers must ensure that patients are fully informed about the off-label nature of the treatment, the potential risks, and the lack of FDA approval for the specific use in question

M., Patterson, E., Carafa, I., et al

Case 1 Male patient died while receiving semaglutide report invalidated because call-center contractors claimed patient identifier was missing (FDA found it in source documents) Case 2 Consumer taking liraglutide suffered a disabling stroke report cancelled because the consumer said it was unrelated to the drug Case 3 Patient taking semaglutide became depressed and committed suicide no follow-up attempts documented, still not submitted to FDA as of March 2026 Case 4 Consumer reported suicidal ideation on semaglutide in December 2024 not reviewed until February 2025, only after FDA inspectors flagged it Case 5 FDA found Novo Nordisk's written procedures allowed adverse events to be rejected based on causality assessments contradicting federal reporting requirements A Second Front: Vision Loss Claims Beyond the GI injury cases, a second GLP-1 MDL was created in December 2025 for vision loss claims

APMIS 127, 688695